1Alpert JS, Thygesen K, Amman E, et al. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction [ J ]. J Am Coll Cardiol, 2000, 36:959 - 969.
2Adams JEB, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury:is MB creative kinase the choice for the 1990s? [ J ]. Circulation, 1993,88 (2) :750 - 763.
3Harem CW,Heeschen C,Goldmann B,et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum tropanin T levels:cTE3 Fab Antiplatelet Therapy in Unstable Refractory Angina(CAPTURE) Study Investigators [ J]. N Engl J Med, 1999,340 : 1623 - 1629.
4Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease ( FRISC ) Study Group [ J ]. J Am Coll Cardiol, 1997,29 : 43 - 48.
5Cohen M,Demers C,Gurfinkel EP,et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group[J]. N Engl J Med, 1997,337:447 :- 452.
6Yusuf S ,Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST- segment elevation [ J ]. N Engl J Med,2001,345 : 494 - 502.
7McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of- care testing of myoglobin and troponin I [ J ]. Circulation, 2001, 104 : 1483 - 1488.
8Ng SM, Krishnaswamy P, Morissey R, et al. Ninety-minute accelerated critical pathway for chest pain evaluation[ J]. Am J Cardiol, 2001,88:611 - 617.
9Rao SV, Ohman EM, Granger CB, et al. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes [ J ]. Am J Cardiol,2003,91:936 -940.
